OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nail toxicities induced by systemic anticancer treatments
Caroline Robert, V. Sibaud, Christina Mateus, et al.
The Lancet Oncology (2015) Vol. 16, Iss. 4, pp. e181-e189
Closed Access | Times Cited: 173

Showing 1-25 of 173 citing articles:

Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
Mario E. Lacouture, V. Sibaud
American Journal of Clinical Dermatology (2018) Vol. 19, Iss. S1, pp. 31-39
Open Access | Times Cited: 293

Dermatological adverse events with taxane chemotherapy
V. Sibaud, Nicole R. LeBoeuf, Henri Roché, et al.
European Journal of Dermatology (2016) Vol. 26, Iss. 5, pp. 427-443
Open Access | Times Cited: 206

Mitigating acute chemotherapy-associated adverse events in patients with cancer
Nicole M. Kuderer, Aakash Desai, Maryam B. Lustberg, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 11, pp. 681-697
Closed Access | Times Cited: 78

Pyogenic Granuloma – A Common Benign Vascular Tumor with Variable Clinical Presentation: New Findings and Treatment Options
Uwe Wollina, Dana Langner, Katlein França, et al.
Open Access Macedonian Journal of Medical Sciences (2017) Vol. 5, Iss. 4, pp. 423-426
Open Access | Times Cited: 130

Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
Mario E. Lacouture, V. Sibaud, Peter Arne Gerber, et al.
Annals of Oncology (2020) Vol. 32, Iss. 2, pp. 157-170
Open Access | Times Cited: 94

Dermatological Toxicities of Bruton’s Tyrosine Kinase Inhibitors
V. Sibaud, M. Beylot‐Barry, Caroline Protin, et al.
American Journal of Clinical Dermatology (2020) Vol. 21, Iss. 6, pp. 799-812
Closed Access | Times Cited: 84

The Diagnosis and Treatment of Nail Disorders
Uwe Wollina, Pietro Nenoff, G. Haroske, et al.
Deutsches Ärzteblatt international (2016)
Open Access | Times Cited: 73

Leukonychia: What Can White Nails Tell Us?
Matilde Iorizzo, Michela Starace, Marcel C. Pasch
American Journal of Clinical Dermatology (2022) Vol. 23, Iss. 2, pp. 177-193
Open Access | Times Cited: 34

Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines
Mario E. Lacouture, V. Sibaud, Milan J. Anadkat, et al.
The Oncologist (2020) Vol. 26, Iss. 2, pp. e316-e326
Open Access | Times Cited: 49

Melanonychia: Etiology, Diagnosis, and Treatment
Archana Singal, Kavita Bisherwal
Indian Dermatology Online Journal (2020) Vol. 11, Iss. 1, pp. 1-1
Open Access | Times Cited: 46

Successful Treatment of MEK Inhibitor-Induced Paronychia in Neurofibromatosis with Photodynamic Therapy: A Case Report and Review of the Therapeutic Options
Francesca Ambrogio, Teresa Perillo, Domenico Bonamonte, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1104-1104
Open Access

EGF receptor in organ development, tissue homeostasis and regeneration
Claudia Tito, Silvia Masciarelli, Gianni Colotti, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access

Modified dermatology life quality index in patients with nail disorders
Richa Kumar, Sandeep Arora, Manasa Shettisara Janney, et al.
(2025), pp. 1-5
Closed Access

Nail Dystrophies Secondary to Chemotherapies
Eden Axler, Shari R. Lipner
(2025), pp. 391-398
Closed Access

Transverse Leukonychia
Kaya L. Curtis, Shari R. Lipner
(2025), pp. 359-365
Closed Access

Pyogenic Granuloma
Brianna Olamiju, Rachel C. Hill, Shari R. Lipner
(2025), pp. 95-102
Closed Access

Acute Paronychia
Apostolos Katsiaunis, Shari R. Lipner
(2025), pp. 3-9
Closed Access

The Effect of Cold Therapy on the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Oncology Patients: A Systematic Review Study
Zeliha Genç, Ayda Kebapçı, Gülbeyaz Can
Seminars in Oncology Nursing (2025), pp. 151849-151849
Closed Access

Acute and Chronic Paronychia
Adam I. Rubin, C. Ralph Daniel
Springer eBooks (2018), pp. 215-225
Closed Access | Times Cited: 38

EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
Lauren Guggina, Andrew W. Choi, Jennifer N. Choi
Oncology and Therapy (2017) Vol. 5, Iss. 2, pp. 135-148
Open Access | Times Cited: 39

Evaluation of Prevention Interventions for Taxane-Induced Dermatologic Adverse Events
Dustin H. Marks, Azam Qureshi, Adam Friedman
JAMA Dermatology (2018) Vol. 154, Iss. 12, pp. 1465-1465
Closed Access | Times Cited: 37

Efficacy of a global supportive skin care programme with hydrotherapy after non-metastatic breast cancer treatment: A randomised, controlled study
Florence Dalenc, Virginie Ribet, Ana B. Rossi, et al.
European Journal of Cancer Care (2017) Vol. 27, Iss. 1, pp. e12735-e12735
Open Access | Times Cited: 33

Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel
Jade Cury‐Martins, Adriana Pessoa Mendes Eris, Cristina Martinez Zugaib Abdalla, et al.
Anais Brasileiros de Dermatologia (2020) Vol. 95, Iss. 2, pp. 221-237
Open Access | Times Cited: 31

Biotin for the treatment of nail disease: what is the evidence?
Shari R. Lipner, Richard K. Scher
Journal of Dermatological Treatment (2017) Vol. 29, Iss. 4, pp. 411-414
Closed Access | Times Cited: 32

Page 1 - Next Page

Scroll to top